![](/img/cover-not-exists.png)
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
Battaglin, Francesca, Schirripa, Marta, Buggin, Federica, Pietrantonio, Filippo, Morano, Federica, Boscolo, Giorgia, Tonini, Giuseppe, Lutrino, Eufemia Stefania, Lucchetti, Jessica, Salvatore, Lisa, PVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4001-x
Date:
December, 2018
File:
PDF, 496 KB
english, 2018